Benefits of lobbying evident for small drugmaker

Tucked in the massive congressional budget bill is a provision that props up the price Medicare pays for a handful of medications, costing taxpayers millions at a time when the Trump administration is vowing to reduce the cost of prescription drugs.

Where Will Facebook Go From Here?

The social media network finally responds to the privacy data breach concerns, and Zuckerberg’s comments raise a few questions about the company’s future.

The Quick and Dirty on Tariffs

President Trump’s steel tariffs will shake up the economy in some major ways, and most of them don’t look promising.